全文获取类型
收费全文 | 1023篇 |
免费 | 58篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 12篇 |
妇产科学 | 6篇 |
基础医学 | 29篇 |
口腔科学 | 12篇 |
临床医学 | 78篇 |
内科学 | 116篇 |
皮肤病学 | 7篇 |
神经病学 | 33篇 |
特种医学 | 37篇 |
外科学 | 112篇 |
综合类 | 81篇 |
预防医学 | 441篇 |
药学 | 74篇 |
肿瘤学 | 39篇 |
出版年
2023年 | 30篇 |
2022年 | 39篇 |
2021年 | 63篇 |
2020年 | 67篇 |
2019年 | 63篇 |
2018年 | 55篇 |
2017年 | 38篇 |
2016年 | 27篇 |
2015年 | 68篇 |
2014年 | 82篇 |
2013年 | 65篇 |
2012年 | 66篇 |
2011年 | 46篇 |
2010年 | 42篇 |
2009年 | 58篇 |
2008年 | 43篇 |
2007年 | 31篇 |
2006年 | 35篇 |
2005年 | 31篇 |
2004年 | 28篇 |
2003年 | 15篇 |
2002年 | 17篇 |
2001年 | 18篇 |
2000年 | 4篇 |
1999年 | 12篇 |
1998年 | 11篇 |
1997年 | 3篇 |
1996年 | 4篇 |
1995年 | 6篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1988年 | 1篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
排序方式: 共有1084条查询结果,搜索用时 15 毫秒
1.
《Value in health》2022,25(12):1958-1966
ObjectivesNational health technology assessments (HTAs) across Europe show differences in evidentiary requirements from assessments by the European Medicines Agency (EMA), affecting time to patient access for drugs after marketing authorization. This article analyzes the differences between EMA and HTA bodies’ evidentiary requirements for oncology drugs and provides recommendations on potential further alignment to minimize and optimally manage the remaining differences.MethodsInterviews were performed with representatives and drug assessment experts from EMA and HTA bodies to identify evidentiary requirements for several subdomains and collect recommendations for potentially more efficiently addressing differences. A comparative analysis of acceptability of the evidence by EMA and the HTA bodies and for potential further alignment between both authorities was conducted.ResultsAcceptability of available evidence was higher for EMA than HTA bodies. HTA bodies and EMA were aligned on evidentiary requirements in most cases. The subdomains showing notable differences concerned the acceptance of limitation of the target population and extrapolation of target populations, progression-free survival and (other) surrogate endpoints as outcomes, cross-over designs, short trial duration, and clinical relevance of the effect size. Recommendations for reducing or optimally managing differences included joint early dialogues, joint relative effectiveness assessments, and the use of managed entry agreements.ConclusionsDifferences between assessments of EMA and HTA bodies were identified in important areas of evidentiary requirements. Increased alignment between EMA and HTA bodies is suggested and recommendations for realization are discussed. 相似文献
2.
叶尔肯·阿布沙特 《国外畜牧学(草食家畜)》2021,(1):63-66
新疆生产建设兵团第十三师位于在新疆东部哈密市,辖区有8个团场。十三师草场面积占兵团草场面积的15.7%,是兵团草场面积最大的师。十三师草原生态十分脆弱,主要以荒漠、半荒漠草场为主。除了部分与地方乡镇接壤草场以外,草场承包确权工作基本完成。由于超载放牧、基础设施落后、防灾减灾能力弱等原因,导致天然草场退化、沙化,有毒、有害植物增加,产草量和草质量明显下降,影响牧民收入。超载放牧是草场退化的根本原因,本文围绕这个主题,对草场面临的困难和难题进行分析,并提出了建设性的建议。通过异地搬迁、办理贷款及改善牧民生产生活等措施,减少天然草原载畜量,减轻夏草场放牧强度,逐步达到草畜平衡的目标,为十三师畜牧业可持续健康发展提供理论基础。 相似文献
3.
G.N. Marta D. Ramiah O. Kaidar-Person A. Kirby C. Coles R. Jagsi T. Hijal G. Sancho Y. Zissiadis J.-P. Pignol A.Y. Ho S.H.-C. Cheng B.V. Offersen I. Meattini P. Poortmans 《Clinical oncology (Royal College of Radiologists (Great Britain))》2021,33(5):322-330
AimsModerately hypofractionated breast irradiation has been evaluated in several prospective studies, resulting in wide acceptance of shorter treatment protocols for postoperative breast irradiation. Reimbursement for radiation therapy varies between private and public systems and between countries, impacting variably financial considerations in the use of hypofractionation. The aim of this study was to evaluate the financial impact of moderately hypofractionated breast irradiation by reimbursement system in different countries.Materials and methodsThe study was designed by an international group of radiation oncologists. A web-questionnaire was distributed to representatives from each country. The participants were asked to involve the financial consultant at their institution.ResultsData from 13 countries from all populated continents were collected (Europe: Denmark, France, Italy, the Netherlands, Spain, UK; North America: Canada, USA; South America: Brazil; Africa: South Africa; Oceania: Australia; Asia: Israel, Taiwan). Clinicians and/or departments in most of the countries surveyed (77%) receive remuneration based on the number of fractions delivered to the patient. The financial loss per patient estimated resulting from applying moderately hypofractionated breast irradiation instead of conventional fractionation ranged from 5–10% to 30–40%, depending on the healthcare provider.ConclusionAlthough a generalised adoption of moderately hypofractionated breast irradiation would allow for a considerable reduction in social and economic burden, the financial loss for the healthcare providers induced by fee-for-service remuneration may be a factor in the slow uptake of these regimens. Therefore, fee-for-service reimbursement may not be preferable for radiation oncology. We propose that an alternative system of remuneration, such as bundled payments based on stage and diagnosis, may provide more value for all stakeholders. 相似文献
4.
5.
Makio Kusaoi Go Murayama Naoto Tamura Ken Yamaji 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2020,24(5):530-547
The aim of this paper was to explain the insurance coverage status of therapeutic apheresis (excluding CHDF) in Japan, alongside the social system of medical reimbursement and concerns regarding the future sustainability of the healthcare system. Insurance schemes and premiums differed for individuals at different levels in the society (eg, municipal residents, employees, and public servants). Insurance premiums and their rates varied depending on the total household income, the number of people living together, age, and the place of residence. In addition, the medical expense subsidies for children through public expenditure were also described. Japan's generous insurance system and multiple medical expense subsidies provide financial support for patients. With Japan's history of medical expense subsidies based on the policy of supporting intractable diseases, we have established an environment where all citizens can receive therapeutic apheresis when needed if they are affected by a disease for which insurance coverage is indicated. 相似文献
6.
7.
本文在梳理英国医保药品报销政策的基础上,通过对价值定价理念的深入研究和理解,系统探讨其在报销政策制定过程中对药品目录遴选、价值测算、支付标准确定、医保基金平衡和报销效益评估的作用机制,并深入思考通过价值定价理念建立起的药物警戒体系与药品报销政策间的衔接机制。在此基础上总结价值定价理念的特点、应用阶段和具体操作方法,以期为我国提供借鉴。 相似文献
8.
目的分析医保投诉的影响因素及解决方案。方法选取2016年1月-2016年12月、2018年1月-2018年12月分别为对照阶段、观察阶段,分别采取常规医保管理、常规医保管理联合优化管理方案,在两个阶段内各随机选取医保支付医疗费用的患者3000例,设为对照组及观察组,分析投诉发生情况;在对照组及观察组内各随机选取患者300例,分析不同阶段服务质量。结果观察组投诉率低于对照组(P<0.05);观察组满意度评分高于对照组(P<0.05)。结论了解医保影响因素,并予以对症解决方案,能够降低医保投诉率,提升医院服务质量及患者满意度。 相似文献
9.
《The Journal for Nurse Practitioners》2021,17(3):258-263
Telehealth is a growing valuable strategy to assist patients accessing needed care when unable to get to a health care setting for one of several reasons. During the coronavirus disease 2019 (COVID-19) pandemic of 2020, many health care practices were forced to implement telehealth services to meet patient and practice needs. In 2020, several temporary waivers, exceptions, and telehealth policy changes emerged across the nation. Many telehealth policies are state or federal specific. This report provides a general overview of essential telehealth policies and legislative updates along with resources and websites to guide and support nurse practitioners with contemporary regulations regarding telehealth billing. 相似文献
10.
Nandita Khera Betty K. Hamilton Joseph A. Pidala William A. Wood Vicky Wu Jenna Voutsinas Lynn Onstad Amin M. Alousi Raewyn Broady George L Chen Mukta Arora Corey Cutler Mary E. Flowers Alex Ganetsky Madan Jagasia Philip L. McCarthy Stefanie Sarantopoulos Gregory A. Abel Stephanie J. Lee 《Biology of blood and marrow transplantation》2019,25(3):599-605
Understanding the socioeconomic impact of chronic graft-versus-host disease (GVHD) on affected patients is essential to help improve their overall well-being. Using data from the Chronic GVHD Consortium, we describe the insurance, employment, and financial challenges faced by these patients and the factors associated with the ability to work/attend school and associated financial burdens. A 15-item cross-sectional questionnaire designed to measure financial concerns, income, employment, and insurance was completed by 190 patients (response rate, 68%; 10 centers) enrolled on a multicenter Chronic GVHD Consortium Response Measures Validation Study. Multivariable logistic regression models examined the factors associated with financial burden and ability to work/attend school. The median age of respondents was 56years, and 87% of the patients were white. A higher proportion of nonrespondents had lower income before hematopoietic cell transplantation and less than a college degree. All but 1 patient had insurance, 34% had faced delayed/denied insurance coverage for chronic GVHD treatments, and 66% reported a financial burden. Patients with a financial burden had greater depression/anxiety and difficulty sleeping. Nonwhite race, lower mental functioning, and lower activity score were associated with a greater likelihood of financial burden. Younger age, early risk disease, and higher mental functioning were associated with a greater likelihood of being able to work/attend school. In this multicenter cohort of patients with chronic GVHD, significant negative effects on finances were observed even with health insurance coverage. Future research should investigate potential interventions to provide optimal and affordable care to at-risk patients and prevent long-term adverse financial outcomes in this vulnerable group. 相似文献